site stats

Satsuma pharmaceuticals news

Webb7 apr. 2024 · Satsuma Pharmaceuticals Inc.’s market cap currently stands at around $24.01 million, with investors looking forward to this quarter’s earnings report slated for … Webb10 sep. 2024 · Shares of Satsuma Pharmaceuticals ( STSA -8.33%) are plunging today, down 74.8% as of 11:17 a.m. EDT, after the company announced that investigational …

Satsuma Pharmaceuticals Appoints Rob Janosky as Chief

Webb2 feb. 2024 · Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company developing a novel therapeutic product, STS101, for the acute treatment of migraine. STS101 is a unique and proprietary nasal powder formulation of the well-established anti-migraine drug, dihydroergotamine mesylate (DHE), administered via Satsuma’s … Webb3 nov. 2024 · SOUTH SAN FRANCISCO, Calif., Nov. 03, 2024 (GLOBE NEWSWIRE) -- Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical … scarecrow property services paignton https://oursweethome.net

Satsuma Pharmaceuticals, Inc. meldet Ergebnis für das vierte …

Webb29 mars 2024 · Satsuma Pharmaceuticals Inc announced deficit of $-70.06 millions and Revenues of $0.00 millions in the fiscal year 2024. Net deficit per share has widen to $ … Webb31 dec. 2024 · Satsuma Pharmaceuticals, Inc. meldete die Ergebnisse für das vierte Quartal zum 31. Dezember 2024. Für das vierte Quartal meldete das Unternehmen einen … WebbFör 1 dag sedan · SOUTH SAN FRANCISCO, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical … scarecrow print out

Satsuma Pharmaceuticals, Inc. (NasdaqGM:STSA) Stock Price & Quote

Category:Satsuma Pharma

Tags:Satsuma pharmaceuticals news

Satsuma pharmaceuticals news

Satsuma Pharmaceuticals, Inc. meldet Ergebnis für das vierte …

Webb28 mars 2024 · Satsuma Pharmaceuticals, Inc. hat am 28. März 2024 seinen 10-K-Bericht für den Zeitraum bis zum 31. Dezember 2024 eingereicht. In diesem Bericht hat der … WebbNews for Satsuma Pharmaceuticals Inc Stock (STSA) Satsuma Pharmaceuticals Announces the Appointment of Mutya Harsch to its Board of Directors. GlobeNewsWire • …

Satsuma pharmaceuticals news

Did you know?

Webb31 dec. 2024 · About Satsuma Pharmaceuticals and STS101 Satsuma Pharmaceuticals is a development-stage biopharmaceutical company developing a novel therapeutic … Webb14 nov. 2024 · Nov 14 (Reuters) - Satsuma Pharmaceuticals Inc (STSA.O) said on Monday its experimental lead treatment for acute migraine headaches failed to meet the main …

WebbSatsuma believes that the data from these Phase 3 Trials – in which a total of more than 1,500 subjects have treated more than 10,000 migraine attacks with STS101 – in combinations with results from its Phase 1 comparative pharmacokinetic studies, will support a New Drug Application filing for STS101. WebbSatsuma Pharmaceuticals Inc. 本社所在地: 400 Oyster Point Boulevard Suite 221 South San Francisco, CA 94080 USA. 電話番号: 650 410-3200. 設立年月: 2016年6月. 代表者名: …

WebbNews for Satsuma Pharmaceuticals Inc Stock (STSA) Satsuma Pharmaceuticals to Present Two Posters at the American Headache Society’s Annual Scientific Meeting … WebbSatsuma Pharmaceuticals Inc (STSA) Stock Price Today, News, Quotes, FAQs and Fundamentals Advertisement 3rd Party Ad. Not an offer or recommendation by …

Webb28 mars 2024 · Satsuma Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported net loss was USD 70.06 million compared to USD 51.17 million a year ago. Basic loss per share from continuing operations was USD 2.19 compared to USD 1.75 a year ago. © S&P Capital IQ 2024

WebbSOUTH SAN FRANCISCO, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company … rugby deathsWebbOur name, “Satsuma Pharmaceuticals” alludes to the origin of the novel dry-powder drug delivery technologies incorporated in STS101. These technologies were initially invented … scarecrow prostheticWebbSatsuma Pharmaceuticals, Inc.からプレスリリースが発表されました. 発表日:2024年3月28日(米国時間). 詳 細:当社重要投資先のSatsuma社は、2024年12月期の通期及び … scarecrow pub kilsythWebbSTSA - Satsuma Pharmaceuticals, Inc. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save to portfolio create alert compare perf. Candle - advanced Intraday Daily Weekly Draw Fullscreen Settings STSA - Stock Price Chart STSA [NASD] scarecrow project for kidsWebbSatsuma Pharmaceuticals to Participate in the Virtual SVB Securities Global Biopharma Conference. SOUTH SAN FRANCISCO, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) -- … scarecrow pub glen nhWebb28 mars 2024 · SOUTH SAN FRANCISCO, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a development-stage … rugby decathlonWebbSatsuma Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Business Highlights TipRanks 152d Wall Street Analysts Are Bullish on Top Healthcare … rugby decals